David Church received a Senior Cancer Research Fellowship from the Cancer Research UK Research Careers Committee to study MHC-I and MHC-II dysregulation in colorectal & endometrial cancer.
A landmark study involving researchers from the Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.
A new home test to diagnose type-1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre and NDM's Centre for Human Genetics.
Five members of the MSc Genomic Medicine teaching team have been awarded Advanced HE fellowships in recognition of their roles in teaching and supporting higher education learning.
Researchers in the CHG have authored a collaborative study which explored a new method for detecting bowel cancer, which was found to be more than 90% accurate at predicting which higher-risk people will develop this type of cancer in the future.
Global biopharma company GSK invests up to \u00a350 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
New research led by Dr Steph Fowler (UCL and now Oxford IMCM), Professor Karen Duff (UKDRI, UCL), with Dr Benjamin Ryskeldi-Falcon and Dr Tiana Behr (MRC LMB), have shed light on a potential pathway for the spread of harmful tau protein in Alzheimer's disease. Their findings, published in Nature Neuroscience, focus on structures called extracellular vesicles and their role in transporting toxic tau fragments.
A new blood test \u2013 powered by machine learning \u2013 has shown real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect. Developed by a team of researchers and co-lead by the Centre for Human Genetics\u2019 Dr Dimitris Vavoulis, the test accurately detected six cancer types and could distinguish between people with and without cancer.
Nicky Whiffin, Associate Professor and Sir Henry Dale Fellow at the University of Oxford\u2019s Big Data Institute and Centre for Human Genetics, has been awarded the 2025 Balfour Lecture by the Genetics Society.
![\"\"](\"https://www.chg.ox.ac.uk/news/david-church-awarded-a-cancer-research-uk-senior-cancer-research-fellowship/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n